Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer and autoimmune disease. For additional information on our guidelines, please visit ww...
Use this information to figure out if this company is an ideal customer for you.
650.457.2700
210 East Grand Avenue
South San Francisco, 94080
501 - 1,000 Employees
$1M - $5M
linkedin.com/company/allogene-therapeutics
Allogene Therapeutics's CEO is David Chang
Allogene Therapeutics's CTO is Tim Moore
Allogene Therapeutics's CFO is Geoffrey Parker
Allogene Therapeutics's HQ is located at 210 East Grand Avenue, South San Francisco
Allogene Therapeutics's phone number is 650.457.2700
Allogene Therapeutics's official website is allogene.com
Allogene Therapeutics's revenue is $1M - $5M
Allogene Therapeutics has 501 - 1,000 employees
Allogene Therapeutics is in the industry of: Biotechnology
